vla, page-23

The big pharmas would want the competitive advantage and certainly dont want any stone un-turned. So in my opinion its a billion dollar industry and VLA would make a nice fit if controlled by a big pharma.
As Keytruda gets more traction in the industry its obvious VLA's profile will be lifted with the joint research, so why not grab VLA while its cheap. I think VLA will be on their shopping list. It certainly would be on my radar if I was a big Pharma.